Debbie Rosenkrantz had a 15 percent chance of surviving rhabdomyosarcoma in 1969 unless she got help from specialists in New York City.
Swelling around her eyelid turned out to be a type of cancer so rare that only a handful of doctors specialized in its treatment. Debbie was the 25th patient treated during the five years that the experimental treatment had been available.
But if she had that treatment, she had an 85 percent chance of survival.
Almost immediately, Debbie and her mother, Emma, were on a plane bound for New York.